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Variations in the transcription factor Gli-similar 3 (GLIS3) gene have been associated
to variable congenital endocrine defects, including both morphogenetic and functional
thyroid alterations. Evidence from Glis3 knockout mice indicates a relevant role for GLIS3
in thyroid hormone biosynthesis and postnatal thyroid gland growth, with a mechanism of
action downstream of the TSH/TSHR interaction. However, the pathophysiological role of
this transcription factor during the embryonic thyroid development remains unexplored.
In this manuscript, we will provide an overview of the current knowledge on GLIS3
function during development. As a perspective, we will present preliminary evidence in
the zebrafish model in support of a potential role for this pleiotropic transcription factor
in the early stages of thyroid gland development.
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GLIS3 IN HUMAN PATHOPHYSIOLOGY
The transcription factor Gli-similar 3 (GLIS3) belongs to the family of the Krüppel-like zinc finger
transcription factor (1) and it is involved in several cellular processes, including proliferation,
apoptosis, differentiation and development (2).
The human GLIS3 gene is located on chromosome 9p24.2 and encodes a full-length protein
of 90 kD in size. GLIS3 in expressed in a tissue-specific manner, with highest levels in kidney,
thyroid gland, endocrine pancreas, thymus, testis, and uterus. Lower levels of expression were also
described in brain, lung, ovary, and liver (1, 3).
Several alternate transcripts of GLIS3 have been reported so far in humans. Nine out of nineteen
isoforms are processed into proteins with unknown functions. The larger transcript (7.5 kb) is
predominantly expressed in pancreas, thyroid, and kidney, whereas the smaller isoforms (0.8–2 kb)
are mainly localized in heart, kidney, liver and skeletal muscle (4). Despite the distinct pattern of
expression, so far there is no evidence of variable pathophysiological functions for these different
transcripts.
The GLIS3 protein consists of a centrally located zinc finger domain (ZFD) (five tandems
Cys2-His2 zinc finger motifs), a C-terminal transactivation domain (TAD) and a relatively large
N-terminus that is important in the regulation of GLIS3 stability and its transcriptional activity
(1, 5).
The ZFD dictatesGLIS3 cytosolic or nuclear localization and is responsible for the recognition of
specific DNA responsive elements, the GlisBS (Glis-binding sites) are located within the regulatory
regions of target genes (1).
Once bound to the DNA, GLIS3 can repress or enhance the expression of target genes (1, 6).
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Furthermore, GLIS3 stability is regulated by the binding
with the “Suppressor of Fused” (SUFU), a negative regulator
of Hedgehog (SHH) signaling, via a YGH motif localized into
the N-terminal domain (7). SUFU not only protects Glis3 from
proteasomal degradation stabilizing Glis3 protein (8), but also
modulates Glis3-mediated transactivation of the promoter of
target genes (9).
Based on the current knowledge, GLIS3 represents a new
candidate gene for congenital hypothyroidism (CH) but its role
in thyroid development and function remains largely unexplored.
Homozygous and compound heterozygous mutations in the
GLIS3 gene have been associated with a rare syndrome, called
NDH, characterized by neonatal diabetes (ND) and CH.
NDH patients frequently present a polycystic kidney disease,
and are variably affected by additional abnormalities, such as
developmental delay, hepatic fibrosis, congenital glaucoma, and
facial dimorphism (1, 3, 10, 11).
The GLIS3 alterations identified in NDH patients included
missense substitutions, frameshift mutations resulting in
premature termination, deletions encompassing exons 5–9, 3–4,
9–11, 10–11 and larger deletions covering regions >100 kb that
include exons 1–2, 1–4, or 5–9 (8).
A Chinese group recently screened GLIS3 gene in 592 CH
patients and 600 controls by Next Generation Sequencing (NGS)
and Multiplex Ligation-dependent Probe Amplification (MLPA)
(12). They found two different variations (one deletion at
chromosome 9p24.3p23, including the GLIS3 gene, and one
missense variant (p.R720Q) in two CH patients with gland-
in-situ (frequency of GLIS3 variations in Chinese CH: 0.3%)
but not in controls. Both variations were in the heterozygous
state (12).
We have recently identified rare heterozygous GLIS3missense
variants by NGS in a large cohort (18/177) of Caucasian
patients with isolated CH (13). Clinically, half of the affected
cases presented variable thyroid dysgenesis (athyreosis, thyroid
hypoplasia, and ectopy), whereas the remaining part have in
situ thyroid gland (13). Interestingly, these GLIS3 variants are
associated in all 18 cases with other rare variations in genes
involved in thyroid pathology, supporting a frequent oligogenic
origin of CH.
Regarding the missense variations identified in NDH or CH
patients no functional studies are available so far. In Figure 1B
we report the alignment of the aminoacid sequences of zebrafish,
mouse and human GLIS3. The residues C536, H561, and R589
associated to NDH pathology localized within the zinc-finger
domain and are completely conserved across species. Concerning
the CH patients (12, 13), only 2/11 missense variants, affect
aminoacids (D512 and E515) belonging the first zinc-finger, but
are not conserved between human and zebrafish.
In addition, a number of genome wide association studies
(GWAS) have associated several GLIS3 single nucleotide
polymorphism (SNP) with elevated circulating TSH levels and
low T4 (1).
Taken together, all of these data support a relevant role of
GLIS3 in thyroid function and in the onset of CH, possibly
contributing to the explanation of the missing hereditability of
CH and the prevalent sporadic presentation of the disease (13).
Although hypothyroidism is associated with GLIS3 variants,
the absence of consistent pathological features in patients makes
unclear the identification of a causative mechanism (8). High
TSH and low T4 characterize all of twelve NDH patients reported
so far, but in presence of a wide spectrum of structural thyroid
abnormalities including athyreosis, hypoplasia, perifollicular,
and interstitial fibrosis, and normal thyroid anatomy. Similar
phenotypic variability was previously observed in patients
with mutations in NKX2.1 and PAX8 genes, involved in the
specification of thyroid primordium and in the subsequent
expression of genes (TG, TPO, TSHR, and NIS) responsible
for the differentiation and proliferation of thyroid follicles
and the synthesis of thyroid hormones (TH) (14, 15). One
possible explanation for the variable CH manifestations could be
attributed to the tissue-specific expression ofGLIS3 transcripts of
variable length. Large deletions or frameshift mutations causing
profound disruptions of Glis3 structure are associated with the
most severe manifestations of NDH. Instead, milder phenotypes
appear correlated to missense substitutions that preserve a
residual function of one or more GLIS3 transcripts (8, 15).
An additional challenge of GLIS3 defect is the high
variability in the sensitivity of TSH suppression during thyroxine
replacement and the consequent difficult TSH normalization
(8). Several patients with elevated TSH and TG levels appear
to be resistant to increasing doses of thyroxine therapy despite
normalization of free T4, thus excluding alterations in the L-T4
absorption (4, 15).
Therefore, additional work is required to understand the
genotype-phenotype correlations and to determine whether
Gils3 acts upstream of genes involved in pathways regulating
thyroid development, hormonogenesis, and the peripheral
response to T4.
GLIS3 MURINE MODELS
Up to now, the murine model has been extensively used
to investigate the pathological mechanism underlying the
multisystem clinical presentation of NDH syndrome, and most
of the researches have been focusing on pancreas development
and the onset of diabetes.
The Glis3-null mice die within 1 week after birth due to
the severity of neonatal diabetes (11). In mutant mice, neonatal
diabetes is associated with decreased insulin levels caused by an
impaired β-cell mass (11, 16), suggesting a relevant role for Glis3
in the regulation of β-cell development and endocrine function
(17).
In fact, Glis3 overlaps with Pdx1 and Nkx6.1 expression in
endocrine progenitors, and becomes mainly restricted to Ins+ β-
cell in later stages (18). ZeRuth and co-workers demonstrated
that Glis3 binds the insulin (Ins) promoter enhancing its
transcription. Glis3 recruits Cbp/p300, which constitutes a
scaffold for the formation of a larger transcriptional regulatory
complex, including the other synergic factors Pdx1, Neurod1,
and Mafa at the level of the insulin promoter (17). All of these
studies indicated that GLIS3 has multiple critical regulatory
functions during pancreas development and also in the adult
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FIGURE 1 | (A) Schematic representation of the zebrafish glis3 protein (UniProt F1QB13). Yellow, Serine-Rich (SR) domain; Green, Proline-Rich (PR) domain; Light
Blue, Zinc-Finger (ZF) domain; Red, Nuclear Localization Signal (NLS). (B) Alignment of the GLIS3 protein sequencing of the zebrafish (UniProt F1QB13), mouse
(UniProt Q0GE24), and human (UniProt Q8NEA6). The color code of the different domains is reported above. The residues that differ between species are highlighted
in gray. The missense GLIS3 variants identified in NDH (orange) and CH (green) patients are reported. (C) Aminoacid identity between zebrafish, murine and human
GLIS3 proteins, performed using ClustalW2 software.
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pancreas: regulating the development of endocrine progenitors,
the generations and maturation of pancreatic β-cells, regulation
of insulin expression as well as in maintaining normal duct
morphology (8).
As for NDH patients, the Glis3 mutant mice also developed
polycystic kidney disease (19), pointing up the role of Glis3 in
the maintenance of the normal renal function. Kang and co-
workers demonstrated thatGlis3 and its co-activatorWwtr1/TAZ
are part of transcriptional regulatory networks that are critical in
the function of the primary cilium (19).
As far as thyroid gland is concerned, the Refetoff and
Jetten groups recently described that Glis3 is essential for TH
biosynthesis and postnatal thyroid gland development in mouse,
acting down-stream of TSH/TSHR system (14). In mice, GLIS3
appears to retain a relevant role in the expression of several
functional proteins, such as the sodium/iodide symporter (Nis
encoded by SCL5A5) and Pendrin (encoded by SLC26A4). In
addition, despite a relevant role in thyroid cell proliferation, no
significant thyroid developmental defects were observed in Glis3
knock-out mice. These data are partially in contrast to those
observed in the NDH patients, in which thyroid dysgenesis is a
common feature. However, several factors, including the type and
site of the mutation, can contribute the variable expression of the
thyroid phenotype (14).
For this reason, we believe that the murine models available
today do not fully recapitulate the clinical manifestations of the
NDH patients. A similar condition was previously experienced
with the knockout ofMCT8 gene in mice that fails to recapitulate
the neurological manifestations of the human disease (20). This
evidence made it clear that a single species would not suffice
to obtain insights into the underlying pathological mechanisms.
The evolutionary conservation of thyroid hormone action on
neurodevelopment as well as the components regulating thyroid
hormone signaling however offered the opportunity to answer
different aspects of MCT8 function in brain development using
different vertebrate species, such as zebrafish (21). In Mct8-
deficient zebrafish embryos, it was possible to obtain the
unprecedented evidence of an impaired thyroid hormone uptake
at the level of the blood-brain barrier during the peri- and
postnatal development (21).
Therefore, in this perspective we address the possibility of
zebrafish as a viable vertebrate model to study in more details the
role of GLIS3 in thyroid morphogenesis and dysfunction.
ZEBRAFISH AS A NEW MODEL TO STUDY
GLIS3 FUNCTIONS
Zebrafish (Danio rerio) has emerged as an important and useful
model system to study different human diseases. Zebrafish
possesses a unique combination of features that makes it
particularly well-suited for experimental and genetic analysis
of vertebrate development. It has a short reproductive cycle
with external fertilization and lays a large numbers of embryos
per mating that can be analyzed under microscope because of
their optical transparency. The availability of several genetic
manipulation strategies, at costs that are definitely lower than
in rodents, lead to the generation of zebrafish models for a wide
variety of human diseases (22).
Like the other vertebrates, the basic unit of the zebrafish
thyroid gland is the thyroid follicle, which arises from the
pharyngeal endoderm (23). At 22 h post-fertilization (hpf) the
zebrafish thyroid primordium starts to express the transcription
factor nkx2.4, pax2a, pax8, hhex, and foxe1. As described in
mice, knockdown experiments in zebrafish demonstrated that
the transcription factor nkx2.4, pax2a, and hhex are required for
the specification and the differentiation of thyroid primordium
(24, 25). The differentiation of thyroid precursors continues
up to 2 days post-fertilization (dpf) with the expression of the
functional thyroid genes tg, tpo, and slc5a5. At 3 dpf the zebrafish
thyroid follicles are completely developed and start to produce
thyroid hormone (24).
Unlike mammals, the zebrafish thyroid is not organized as a
compact gland, but is composed of single follicles localized along
the ventral aorta (23). In fact, alterations in the architecture of
the pharyngeal vessels are associated with severe thyroid defects,
consistent with a correlation between thyroid morphology and
vascular development (25). The proper amount of TH is tightly
regulated by the hypothalamus-pituitary-thyroid axis, which is
also preserved in zebrafish (24). As a consequence, this model
has been extensively used to study the molecular mechanism
underlying alteration in thyroid development (23, 25, 26) and
function (27, 28). However, the mechanisms and the genes
accounting for the commitment of the thyroid precursors from
the endoderm are presently unknown.
The glis3 gene is evolutionary conserved across species dating
back to fishes (2) and in zebrafish it is localized on the
chromosome 10 and encodes a protein of 804 residues that is
88.45 kD in size. A second transcript that encodes protein of 787
residues still not characterized to date. Although the aminoacid
identity between zebrafish and human is rather low (47.23%),
the glis3 protein structure and the five zinc-finger motives are
well-conserved also in zebrafish (Figure 1).
By in situ hybridization (ISH), we show that the zebrafish glis3
transcript is expressed since the early developmental stages with
an intense signal at the pharyngeal endoderm, brain and in the
glomerulus and the pronephric ducts. Of note, glis3 transcripts
are not detectable when the thyroid gland development is
completed at 3 dpf (Figure 2A). During embryonic development
glis3 starts to be expressed during somitogenesis with a peak at
20-somite stage (19 hpf). Afterwards, the glis3 levels increase
rapidly until the embryonic transition to the larval stage
(Figure 2B). Consistent with clinical and experimental findings
in humans and mice models, glis3 is expressed in a tissue specific
manner in the adult zebrafish. It is detectable at high level in
kidney, pituitary and pancreas and at lower levels in testis, ovary,
brain, and pectoral fins (Figure 2C).
The only available findings about the glis3 function in
zebrafish are now-a-days related to pancreas. The glis3
knockdown embryos present Type 2 Diabetes (T2D) and a
β-cell mass deficiency (30), confirming findings in mice (11).
Both Glis3 and Wwtr1 are known to contribute to renal
function (19). Interestingly, wwtr1 has been shown to have
an important function in the antero-posterior pattering of the
Frontiers in Endocrinology | www.frontiersin.org 4 November 2018 | Volume 9 | Article 730
Rurale et al. GLIS3 and Thyroid
FIGURE 2 | Ontogenetic pattern of glis3 expression in zebrafish. (A) Tissue specific expression of glis3, at different developmental stages, analyzed by ISH using glis3
antisense riboprobe followed by NBT/BCIP staining, as previously described (29). Images are representative of three experiments (30 embryos each). (B,C) qRT-PCR
of glis3 relative mRNA expression during embryonic development and adult tissues. Total RNA is extracted from pools of 50 embryos/stage and from 3 adults,
respectively. cDNA synthesis and qRT-PCR following standard procedures (28). Experiments are performed in triplicate and results are expressed by Mean ± SD.
pronephric progenitor field (31) as well as in the differentiation
of the thyroid gland (32) in zebrafish. It is therefore tempting
to hypothesize a possible interaction between glis3 and wwtr1
during thyroid growth. To date, the involvement of glis3 in
the development and function of the thyroid gland and of
the hypothalamic-pituitary-thyroid axis in zebrafish is presently
unknown. The expression of glis3 at the pharyngeal endoderm
before the appearance of nkx2.4 and pax2a expression in the
thyroid primordium suggests a possible role for glis3 during the
specification of the thyroid precursors, and this hypothesis is
currently under investigation in our Lab.
CONCLUSION
To date, it is known that GLIS3 is a pleiotropic master regulator
of several pathways involved in the development and function
of a broad range of tissues and organs. In particular, GLIS3
is involved in the specification of several endocrine glands.
Since the endocrine pancreas and thyroid arise from the same
embryonic sheet, it is reasonable to think that GLIS3 could act at
both sites with similar mechanisms. However, based on current
findings it is possible to envisage a dual role for GLIS3 during
the thyroid development and regulating thyroid function in the
postnatal period.
The bewildering variability of the clinical manifestations
of NDH and CH associated with GLIS3 variants cannot
be explained at present. Hence, there is need to improve
our understanding of the pathophysiology underlying GLIS3
action.
The establishment of a zebrafish model may constitute a valid
alternative to mice in the definition of the early effects of glis3
deficiency and, eventually, provide interesting insights on the
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molecular mechanisms involved in thyroid development and CH
pathogenesis.
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